Kim Dong has filed 7 insider transactions across 1 company since March 2022.
Most recent transaction: a option exercise of 2500 shares of UroGen Pharma Ltd. ($URGN) on September 09, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 9, 2024 | UroGen Pharma Ltd. | $URGN | Kim Dong | Chief Financial Officer | M | Ordinary Shares | 2500 | $0.00 | 37,753.0000 | 40,501,315 | 7.09% | 0.01% |
| Sept. 9, 2024 | UroGen Pharma Ltd. | $URGN | Kim Dong | Chief Financial Officer | M | Restricted Stock Units | 2500 | $0.00 | 5,000.0000 | 40,501,315 | 33.33% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Kim Dong | Chief Financial Officer | M | Ordinary Shares | 3333 | $0.00 | 35,253.0000 | 36,153,634 | 10.44% | 0.01% |
| March 25, 2022 | UroGen Pharma Ltd. | $URGN | Kim Dong | Chief Financial Officer | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Kim Dong | Chief Financial Officer | M | Ordinary Shares | 3333 | $0.00 | 26,585.0000 | 36,153,634 | 14.33% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Kim Dong | Chief Financial Officer | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 36,153,634 | 33.33% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Kim Dong | Chief Financial Officer | A | Restricted Stock Units | 12000 | $0.00 | 12,000.0000 | 36,153,634 | 9999.99% | 0.03% |